A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients

PHASE4UnknownINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 30, 2018

Conditions
Alzheimer Disease
Interventions
DRUG

Choline alfoscerate

DRUG

Placebo

Trial Locations (1)

Unknown

RECRUITING

Seoul National University Bundang Hospital, Sungnam

All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY